Segall Bryant & Hamill, LLC Zoetis Inc. Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

A detailed history of Segall Bryant & Hamill, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 73,528 shares of ZTS stock, worth $12.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

73,528

Previous 70,953 3.63%

Holding current value

$12.2 Million

Previous $12.3 Million 16.79%

% of portfolio

0.2%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$172.58 - $196.48 $444,393 - $505,936	2,575 Added 3.63%	73,528 $14.4 Million
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $974,826 - $1.2 Million	6,698 Added 10.42%	70,953 $12.3 Million
Q1 2024 May 15, 2024	SELL	$165.67 - $199.94 $1.75 Million - $2.12 Million	-10,592 Reduced 14.15%	64,255 $10.9 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $84.2 Million - $111 Million	-555,969 Reduced 88.13%	74,847 $14.8 Million
Q3 2023 Nov 09, 2023	SELL	$167.14 - $192.77 $2.94 Million - $3.4 Million	-17,618 Reduced 2.72%	630,816 $110 Million
Q2 2023 Aug 11, 2023	SELL	$160.94 - $186.23 $5.35 Million - $6.2 Million	-33,266 Reduced 4.88%	648,434 $112 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $427,856 - $514,733	2,941 Added 0.43%	681,700 $113 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $89 Million - $107 Million	678,759 New	678,759 $99.5 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $94.1 Million - $116 Million	634,767 New	634,767 $94.1 Million
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $1.46 Million - $1.87 Million	-9,344 Reduced 1.49%	615,885 $106 Million
Q1 2022 May 13, 2022	SELL	$181.39 - $234.03 $1.83 Million - $2.36 Million	-10,071 Reduced 1.59%	625,229 $118 Million
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $7.37 Million - $9.41 Million	-38,073 Reduced 5.65%	635,300 $155 Million
Q3 2021 Nov 03, 2021	SELL	$189.29 - $209.69 $2.79 Million - $3.09 Million	-14,751 Reduced 2.14%	673,373 $131 Million
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $2.21 Million - $2.66 Million	14,168 Added 2.1%	688,124 $128 Million
Q1 2021 May 13, 2021	SELL	$144.0 - $169.39 $2.22 Million - $2.61 Million	-15,415 Reduced 2.24%	673,956 $106 Million
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $1.04 Million - $1.15 Million	6,620 Added 0.97%	689,371 $114 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $3.16 Million - $3.81 Million	23,044 Added 3.49%	682,751 $113 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $1.28 Million - $1.63 Million	-11,433 Reduced 1.7%	659,707 $90.4 Million
Q1 2020 May 14, 2020	SELL	$92.66 - $144.94 $1.45 Million - $2.27 Million	-15,636 Reduced 2.28%	671,140 $79 Million
Q4 2019 Feb 11, 2020	BUY	$116.25 - $133.25 $3.96 Million - $4.54 Million	34,084 Added 5.22%	686,776 $90.9 Million
Q3 2019 Nov 12, 2019	SELL	$112.57 - $128.43 $3.32 Million - $3.78 Million	-29,470 Reduced 4.32%	652,692 $81.3 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $3.23 Million - $3.77 Million	-32,995 Reduced 4.61%	682,162 $0
Q1 2019 May 15, 2019	BUY	$81.56 - $100.67 $1.38 Million - $1.7 Million	16,921 Added 2.42%	715,157 $0
Q4 2018 Feb 15, 2019	BUY	$79.28 - $95.27 $960,318 - $1.15 Million	12,113 Added 1.77%	698,236 $59.7 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $1.13 Million - $1.26 Million	-13,520 Reduced 1.93%	686,123 $0
Q2 2018 Aug 08, 2018	BUY	$79.9 - $89.2 $4.63 Million - $5.17 Million	58,006 Added 9.04%	699,643 $0
Q1 2018 May 16, 2018	BUY	$71.51 - $84.69 $483,336 - $572,419	6,759 Added 1.06%	641,637 $0
Q4 2017 Feb 15, 2018	SELL	$63.24 - $72.8 $8.59 Million - $9.89 Million	-135,869 Reduced 17.63%	634,878 $0
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $46 Million - $50.4 Million	770,747	770,747 $0

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

411M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account

Segall Bryant & Hamill, LLC Zoetis Inc. Transaction History